J.P. Morgan Notebook Day 1: Pfizer, Gilead, Alnylam, Novartis, Sarepta, Deal Trends And Cell Therapy Challenges

 
• By Jessica Merrill, Mandy Jackson, Emily Hayes, and Mike Ward
  
San Francisco Skyline with Dramatic Clouds at Sunrise, California, USA - Image

More from Pricing Debate

More from Market Access